| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 03/06/2002 | CN1338940A Bidifobacterium in the treatment of inflammatory disease |
| 03/06/2002 | CN1338936A Drug-combinations comprising (E)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl](3R,5S)-3,5-dihydroxyhept-6-enoic acid and an inhibitor, inducer or substrate of P450 |
| 03/06/2002 | CN1338935A Release-regulating preparations |
| 03/06/2002 | CN1338928A Combinations of formoterol and a tiotropium salt |
| 03/06/2002 | CN1338927A Injection molding method for (meta) acrylate copolymers having tertiary ammonium groups |
| 03/06/2002 | CN1338926A 可食用的包衣组合物 Edible coating composition |
| 03/06/2002 | CN1338925A Enteric coated pharmaceutical tablet and method of manufacturing |
| 03/06/2002 | CN1338924A Polymeric delivery agents and delivery agent compounds |
| 03/06/2002 | CN1338923A Method for controlling liposome size |
| 03/06/2002 | CN1338902A Smoking products containing antioxidants |
| 03/06/2002 | CN1338300A Moistening ointment for treating burn and scald |
| 03/06/2002 | CN1338297A Orally applied medicine 'Gukangwang' for treating arthropathy and its preparing process |
| 03/06/2002 | CN1338291A Chinese medicine for treating hypotension |
| 03/06/2002 | CN1338282A Bone-setting medicine and its preparing process |
| 03/06/2002 | CN1338275A Chinese-medicinal extract with alpha-glucosidase inhibitor activity, and its preparing process and application |
| 03/06/2002 | CN1338268A Anticough lung-moistening jelly and its preparing process |
| 03/06/2002 | CN1338258A Antibacterial clindamycin phosphate powder injection and its preparing process |
| 03/06/2002 | CN1338257A Cream for treating dermatopathy |
| 03/06/2002 | CN1338255A Oily gammariza injection |
| 03/06/2002 | CN1080125C Oral pharmaceutical dosage forms comprising a proton pump inhibitor and an antacid agent or alginate |
| 03/06/2002 | CN1080123C Prolonged delivery of peptides |
| 03/06/2002 | CN1080122C Medicine for injury pain and its preparation |
| 03/06/2002 | CN1080120C Pharmaceutical compositions |
| 03/06/2002 | CN1080119C Pharmaceutical composition contg. proton pump inhibitors |
| 03/06/2002 | CN1080118C Freeze-dried ondanstetron compositions |
| 03/06/2002 | CN1080114C Power formulations containing melezitose as diluent |
| 03/06/2002 | CN1080113C Oral gel capsule formulation of 1,2,4-benzotriazine oxides |
| 03/06/2002 | CN1080109C Apparatus and method for spreading gelatin coating onto tablets |
| 03/06/2002 | CN1080108C Apparatus and method for gelatin coating tablets |
| 03/06/2002 | CN1080107C Apparatus for gelatin coating tablets |
| 03/05/2002 | US6353055 Polycation homopolymer or copolymer |
| 03/05/2002 | US6353034 Fatty alcohols with polyglycosides |
| 03/05/2002 | US6353031 Bathing composition for analgesics |
| 03/05/2002 | US6353030 Relating to organic compounds |
| 03/05/2002 | US6353029 Storage stable tretinoin and 4-hydroxyanisole containing topical composition |
| 03/05/2002 | US6353004 Peripherally acting anti-pruritic opiates |
| 03/05/2002 | US6352998 A topical composition of a compound of the fk506 class in an alkanediol, ether diol, or diether alcohol solvent, an unsaturated fatty alcohol and water used as an antiinflammatory and antihyperproliferative for skin diseases |
| 03/05/2002 | US6352996 Liposomal prodrugs comprising derivatives of camptothecin and methods of treating cancer using these prodrugs |
| 03/05/2002 | US6352978 Pharmaceutical compositions containing tobramycin and xanthan gum |
| 03/05/2002 | US6352974 Oral calcitonin pharmaceutical compositions and methods of making the same |
| 03/05/2002 | US6352737 Use of nanoscale sterols and sterol esters |
| 03/05/2002 | US6352729 Administering melothria plant extract to subjects having sepsis; preventing cytokine release |
| 03/05/2002 | US6352722 Time-release agent comprising trehalose diisobutyrate hexaacetate and fluticasone; drug delivery |
| 03/05/2002 | US6352721 Hydrophilic polymer core; membrane comprising mixture of cellulose acylate, poly(methacrylate) copolymer salt and plasticizer; microporous passageways |
| 03/05/2002 | US6352720 Tablet with extra-granular disintegrant; administering orally to treat bacterial infections |
| 03/05/2002 | US6352719 Multilayer of hydroxypropyl methyl cellulose seal, adhesion promoting propylene glycol alginate, and sodium alginate barrier |
| 03/05/2002 | US6352718 Vasopressin antagonist formulation and process |
| 03/05/2002 | US6352717 Process for encapsulating shear sensitive fill masses into capsules and capsules containing shear sensitive fill masses |
| 03/05/2002 | US6352716 Mixing cholesterol hemisuccinate salt with fungicide or peptide; agitation to form vesicles; solvent-free |
| 03/05/2002 | US6352715 Sheet of drug-impermeable backing laminate supports huperzine a dispersing pressure sensitive adhesive |
| 03/05/2002 | US6352713 Chewable, non-acidic prenatal tablet containing vitamin c derivative, folic acid, flavor, and glycyrrizin sweetener; gastrointestinal side effect reduction; no tooth enamel erosion |
| 03/05/2002 | US6352711 Mucoadhesive comprising microbiocide, dexamethasone, and diphenhydramine; analgesic, antihistamine, and antiinflammatory agents; secondary infection prevention |
| 03/05/2002 | US6352710 A compliant poly(ethylene glycol)-oligotrimethylene carbonate copolymer on a tissue surface, wherein the normalized compliance ratio of the tissue and the material is about 0.5 to 3 |
| 03/05/2002 | US6352707 Comprising gelatin, dextran, nitric oxide inhibitor, and arginine, lysine, histidine, glutamic acid, or aspartic acid |
| 03/05/2002 | US6352701 Stable hydroalcoholic compositions |
| 03/05/2002 | US6352697 Immunostimulating complex matrices; quil a fractions |
| 03/05/2002 | US6352686 Antipsoriatic nail polish |
| 03/05/2002 | US6352684 Nonionic surfactant; reduces ozone depletion potential |
| 03/05/2002 | US6352682 Polymeric delivery of radionuclides and radiopharmaceuticals |
| 03/05/2002 | CA2133598C Non-occlusive adhesive patch for applying medication to the skin |
| 03/05/2002 | CA2098984C Drug delivery system |
| 03/05/2002 | CA2081269C Penetration enhancement of topically applied formulations |
| 03/05/2002 | CA2059855C Controlled release compositions |
| 03/05/2002 | CA2051531C Superior tasting pharmaceutical composition having porous particles and the process of preparing such pharmaceutical composition |
| 03/01/2002 | CA2356786A1 Solid peptide preparations for inhalation and their preparation |
| 02/28/2002 | WO2002016442A2 Microparticle composition and method |
| 02/28/2002 | WO2002016333A2 Thioflavin derivatives and their use in diagnosis and theraphy of alzheimer's disease |
| 02/28/2002 | WO2002016309A1 Compounds and compositions for delivering active agents |
| 02/28/2002 | WO2002016046A1 Moving liquid into and along micro-fluidic channels |
| 02/28/2002 | WO2002015965A2 Constant rate fluid delivery device with selectable flow rate and titratable bolus button |
| 02/28/2002 | WO2002015962A2 Apparatus and method for delivery of drugs or gene therapy vasculature |
| 02/28/2002 | WO2002015959A2 Compounds and compositions for delivering active agents |
| 02/28/2002 | WO2002015940A2 Solution of an oxazolidinone antibiotic drug |
| 02/28/2002 | WO2002015938A2 Testosterone ester formulation for human use |
| 02/28/2002 | WO2002015937A2 Pharmaceutical composition for the systematic administration of pharmacologically active ingredients containing polyol fatty acid esters |
| 02/28/2002 | WO2002015936A1 Antifungal ketoconazole composition for topical use |
| 02/28/2002 | WO2002015913A1 Treatment of trauma, and other indications |
| 02/28/2002 | WO2002015908A1 Injections |
| 02/28/2002 | WO2002015903A2 Novel pharmaceutical composition for administering n-0923 |
| 02/28/2002 | WO2002015900A1 Ibuprofen solutions for capsule-filling and capsule prepartions |
| 02/28/2002 | WO2002015890A1 Transdermal therapeutic system |
| 02/28/2002 | WO2002015889A1 Transdermal therapeutic system for treating restless-legs-syndrome |
| 02/28/2002 | WO2002015888A1 Drug-release controlling system |
| 02/28/2002 | WO2002015887A1 Consumable container |
| 02/28/2002 | WO2002015886A2 Oral fast-melt dosage form of a cyclooxygenase-2 inhibitor |
| 02/28/2002 | WO2002015885A2 Oral fast-melt formulation of a cyclooxygenase-2 inhibitor |
| 02/28/2002 | WO2002015884A2 Rapidly disintegrating oral formulation of a cyclooxygenase-2 inhibitor |
| 02/28/2002 | WO2002015883A1 A method of stabilizing a dry powder pharmaceutical formulation |
| 02/28/2002 | WO2002015882A1 Delayed release compositions and combinations |
| 02/28/2002 | WO2002015881A2 Use of a porous carrier |
| 02/28/2002 | WO2002015880A2 Powdered mannitol and mannitol-containing compositions |
| 02/28/2002 | WO2002015879A1 A method of treating a systemic disease |
| 02/28/2002 | WO2002015878A1 Aqueous suspension preparations |
| 02/28/2002 | WO2002015877A2 Methods and compositions for targeted delivery |
| 02/28/2002 | WO2002015876A2 Amorphous carrier materials for drug delivery |
| 02/28/2002 | WO2002015871A1 Use of tyramine in cosmetic compositions to lighten the skin |
| 02/28/2002 | WO2002015851A2 Storage stable tretinoin and 4-hydroxy anisole containing topical composition |
| 02/28/2002 | WO2002015844A2 Antimicrobial composition and methods of use in the treatment of disease |
| 02/28/2002 | WO2002015832A1 Non-hormonal vaginal contraceptive |
| 02/28/2002 | WO2002015828A2 Prevention of posterior capsular opacification by endocapsular circulation of chemical agents |